Intensive lipid-lowering therapy: Obvious benefits, possible risks

Eyal Zimlichman; Martine Szyper-Kravitz; Uriel Katz; Yehuda Shoenfeld

Intensive lipid-lowering therapy: Obvious benefits, possible risks

Eyal Zimlichman^*, Martine Szyper-Kravitz, Uriel Katz, Yehuda Shoenfeld

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	890-891
Number of pages	2
Journal	Israel Medical Association Journal
Volume	8
Issue number	12
State	Published - Dec 2006

Keywords

Cholesterol
Ezetimibe
Myopathy
Statins

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{e92b5338be3d4dfe8e7fde0d6d9890d3,

title = "Intensive lipid-lowering therapy: Obvious benefits, possible risks",

keywords = "Cholesterol, Ezetimibe, Myopathy, Statins",

author = "Eyal Zimlichman and Martine Szyper-Kravitz and Uriel Katz and Yehuda Shoenfeld",

year = "2006",

month = dec,

language = "אנגלית",

volume = "8",

pages = "890--891",

journal = "Israel Medical Association Journal",

issn = "1565-1088",

publisher = "Israel Medical Association",

number = "12",

}

TY - JOUR

T1 - Intensive lipid-lowering therapy

T2 - Obvious benefits, possible risks

AU - Zimlichman, Eyal

AU - Szyper-Kravitz, Martine

AU - Katz, Uriel

AU - Shoenfeld, Yehuda

PY - 2006/12

Y1 - 2006/12

KW - Cholesterol

KW - Ezetimibe

KW - Myopathy

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=33845864695&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:33845864695

SN - 1565-1088

VL - 8

SP - 890

EP - 891

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

IS - 12

ER -

Intensive lipid-lowering therapy: Obvious benefits, possible risks

Keywords

UN SDGs

Other files and links

Cite this